Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting
FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy
Flavopiridol Plus Cisplatin Tested In Phase II Trial
Trial Combines Drugs Against Blood Vessel Formation
Bevacizumab And Irinotecan May Increase Survival Of GBM
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters - More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data in ACS guideline support greater use of noninvasive tests to ease system strain, save lives - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- David Gius assumes role of director of the University of Cincinnati Cancer Center









